Indivior PLC
INDV21.010USD
-0.040-0.19%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
2.63BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Indivior PLC Unternehmen
Indivior PLC is a pharmaceutical company. The Company is engaged in developing medicines to treat substance use disorders (SUD), serious mental illnesses, and opioid overdose. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder, and co-morbidities, including schizophrenia. Its core products include SUBLOCADE (buprenorphine extended release) monthly injection; SUBOXONE Film (buprenorphine and naloxone sublingual film); SUBOXONE Tablet (buprenorphine and naloxone sublingual tablets), and SUBUTEX Tablet (buprenorphine sublingual tablets). Its products for the treatment of opioid disorders (OUD) are OPVEE (nalmefene) nasal spray for opioid overdose reversal, and PERSERIS (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults in the United States. Its portfolio of products is available in 37 countries.
Unternehmensinformationen
BörsenkürzelINDV
Name des UnternehmensIndivior PLC
IPO-datumDec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
Anzahl der mitarbeiter1030
WertpapierartOrdinary Share
GeschäftsjahresendeDec 24
Addresse234 Bath Road
StadtSLOUGH
BörseNASDAQ Global Select Consolidated
LandUnited Kingdom
PostleitzahlSL1 4EE
Telefon448043791090
Websitehttps://www.indivior.com/en
BörsenkürzelINDV
IPO-datumDec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
9.63K
+150.00%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
3.88K
+63.05%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
760.00
--
Mr. Stuart (Tony) Kingsley
Mr. Stuart (Tony) Kingsley
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
222.00M
83.46%
Rest of World
44.00M
16.54%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Wed, Jul 2
Aktualisiert: Wed, Jul 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Two Seas Capital LP
9.35%
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.47%
BlackRock Investment Management (UK) Ltd.
6.63%
Goldman Sachs International
6.58%
Other
60.15%
Aktionäre
Aktionäre
Anteil
Two Seas Capital LP
9.35%
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.47%
BlackRock Investment Management (UK) Ltd.
6.63%
Goldman Sachs International
6.58%
Other
60.15%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
39.97%
Investment Advisor/Hedge Fund
20.90%
Investment Advisor
14.44%
Research Firm
10.94%
Individual Investor
3.88%
Pension Fund
0.36%
Family Office
0.21%
Bank and Trust
0.20%
Venture Capital
0.04%
Other
9.06%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
349
120.01M
95.70%
+8.27M
2025Q1
380
119.99M
96.15%
-1.70M
2024Q4
382
116.83M
93.64%
-10.43M
2024Q3
369
117.73M
91.72%
-15.91M
2024Q2
352
119.29M
90.10%
-8.99M
2024Q1
341
129.79M
96.57%
+3.79M
2023Q4
322
124.43M
92.28%
+2.93M
2023Q3
321
114.40M
84.40%
+17.06M
2023Q2
296
115.50M
83.90%
+12.51M
2023Q1
259
96.50M
70.33%
+1.18M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Two Seas Capital LP
12.07M
9.68%
+191.47K
+1.61%
Jun 17, 2025
Oaktree Capital Management, L.P.
11.01M
8.82%
+293.23K
+2.74%
Mar 31, 2025
Deerfield Management Company, L.P.
10.57M
8.47%
+4.00M
+60.90%
Mar 31, 2025
BlackRock Investment Management (UK) Ltd.
8.27M
6.63%
+8.27M
--
Jun 27, 2025
Goldman Sachs International
8.21M
6.58%
+1.28M
+18.51%
Mar 31, 2025
Madison Avenue Partners LP
7.79M
6.25%
+2.76M
+54.85%
Mar 31, 2025
Rubric Capital Management LP
4.70M
3.77%
+1.17M
+33.20%
Apr 21, 2025
The Vanguard Group, Inc.
4.61M
3.69%
+71.54K
+1.58%
Mar 31, 2025
UBS Financial Services, Inc.
3.53M
2.83%
+2.69M
+323.54%
Mar 31, 2025
Sirovich (Matthew I.)
3.42M
2.74%
+249.62K
+7.87%
Sep 30, 2024
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
iShares MSCI United Kingdom Small-Cap ETF
0.34%
ProShares Ultra Nasdaq Biotechnology
0.21%
Invesco Nasdaq Biotechnology ETF
0.21%
Franklin US Small Cap Multifactor Index ETF
0.17%
Vanguard US Multifactor ETF
0.16%
Invesco International BuyBack Achievers ETF
0.13%
iShares Intl Small Cap Equity Factor ETF
0.11%
SPDR S&P International Small Cap ETF
0.11%
iShares MSCI Europe Small-Cap ETF
0.1%
iShares Russell 2000 Growth ETF
0.09%
Mehr Anzeigen
iShares MSCI United Kingdom Small-Cap ETF
Anteil0.34%
ProShares Ultra Nasdaq Biotechnology
Anteil0.21%
Invesco Nasdaq Biotechnology ETF
Anteil0.21%
Franklin US Small Cap Multifactor Index ETF
Anteil0.17%
Vanguard US Multifactor ETF
Anteil0.16%
Invesco International BuyBack Achievers ETF
Anteil0.13%
iShares Intl Small Cap Equity Factor ETF
Anteil0.11%
SPDR S&P International Small Cap ETF
Anteil0.11%
iShares MSCI Europe Small-Cap ETF
Anteil0.1%
iShares Russell 2000 Growth ETF
Anteil0.09%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
